These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8029313)

  • 21. CNV, PINV and probe-evoked potentials in schizophrenics.
    Wagner M; Rendtorff N; Kathmann N; Engel RR
    Electroencephalogr Clin Neurophysiol; 1996 Feb; 98(2):130-43. PubMed ID: 8598173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiological brain activity and antisaccade performance in schizophrenia patients with first-rank (passivity) symptoms.
    Waters F; Price G; Dragović M; Jablensky A
    Psychiatry Res; 2009 Dec; 170(2-3):140-9. PubMed ID: 19906434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response of negative symptoms of schizophrenia to neuroleptic treatment.
    Serban G; Siegel S; Gaffney M
    J Clin Psychiatry; 1992 Jul; 53(7):229-34. PubMed ID: 1639741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Usefulness of standardized psychometric scales (BPRS, HDS)in the evaluation of schizophrenic symptoms (preliminary report)].
    Linka M; Rybakowski J
    Psychiatr Pol; 1990; 24(1):15-22. PubMed ID: 2284354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [French translation of the Chapman Social and Physical Anhedonia Questionnaire: validation of the French translation in controls and schizophrenic patients].
    Assouly-Besse F; Dollfus S; Petit M
    Encephale; 1995; 21(4):273-84. PubMed ID: 7588166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of reaction time in post-acute schizophrenia using electrophysiologic variables].
    Eichert V; Klosterkötter J
    Fortschr Neurol Psychiatr; 1996 Jul; 64(7):261-70. PubMed ID: 8765892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].
    Bralet MC; Yon V; Loas G; Noisette C
    Encephale; 2000; 26(6):32-41. PubMed ID: 11217537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facial expression and face orientation processing in schizophrenia.
    Doop ML; Park S
    Psychiatry Res; 2009 Dec; 170(2-3):103-7. PubMed ID: 19896209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N400 abnormalities in late life schizophrenia and related psychoses.
    Olichney JM; Iragui VJ; Kutas M; Nowacki R; Jeste DV
    Biol Psychiatry; 1997 Jul; 42(1):13-23. PubMed ID: 9193737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The value of cognitive psychophysiological studies in a comprehensive approach to schizophrenia (treatment of information and attention capacities in acute-stage schizophrenia)].
    Lembreghts M; Timsit-Berthier M
    Acta Psychiatr Belg; 1993; 93 Spec No():322-42. PubMed ID: 8091994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early visual components (P100, N170) are disrupted in chronic schizophrenic patients: an event-related potentials study.
    Campanella S; Montedoro C; Streel E; Verbanck P; Rosier V
    Neurophysiol Clin; 2006; 36(2):71-8. PubMed ID: 16844545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia.
    Orsel S; Akdemir A; Dağ I
    Compr Psychiatry; 2004; 45(1):57-61. PubMed ID: 14671738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Wisconsin Card Sort Test and P300 responses to novel auditory stimuli in schizophrenic patients.
    Merrin EL; Floyd TC; Deicken RF; Lane PA
    Int J Psychophysiol; 2006 Jun; 60(3):330-48. PubMed ID: 16143413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Positive and negative symptoms in chronic schizophrenic patients under maintenance therapy with flupenthixol decanoate for a twelve month perioid].
    Pach J; Finkbeiner T; Glaser T; Haug J; Osterheider M; Tegeler J
    Fortschr Neurol Psychiatr; 1998 Oct; 66(10):442-9. PubMed ID: 9825249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Saccadic reaction times and visuospatial disorders of attention in schizophrenic patients with negative symptoms].
    Mackert A; Flechtner M; Frick K
    Fortschr Neurol Psychiatr; 1989 Dec; 57(12):535-43. PubMed ID: 2613156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contingent negative variation in patients with deficit schizophrenia or bipolar I disorder with psychotic features: measurement and correlation with clinical characteristics.
    Li Z; Deng W; Liu X; Zheng Z; Li M; Li Y; Han Y; Ma X; Wang Q; Liu X; Li T
    Nord J Psychiatry; 2015 Apr; 69(3):196-203. PubMed ID: 25263850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathophysiologic regulatory mechanisms in chronic schizophrenia].
    Klempel K
    Fortschr Neurol Psychiatr; 1991 Jun; 59(6):239-46. PubMed ID: 1885122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slow EEG potentials (contingent negative variation and post-imperative negative variation) in schizophrenia: their association to the present state and to Parkinsonian medication effects.
    Verleger R; Wascher E; Arolt V; Daase C; Strohm A; Kömpf D
    Clin Neurophysiol; 1999 Jul; 110(7):1175-92. PubMed ID: 10423184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The contingent negative variation in positive and negative types of schizophrenia.
    Oke S; Saatchi R; Allen E; Hudson NR; Jervis BW
    Am J Psychiatry; 1994 Mar; 151(3):432-3. PubMed ID: 8109655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.